Recruiting
Dermatitis atopic
RecruitingSafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)
Investigational
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)
Investigational
- Disease:Dermatitis atopic
- Substances:Soquelitinib
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Soquelitinib
- Sponsor:Corvus Pharmaceuticals Inc.




